Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2022

01-04-2022 | Community-Acquired Pneumonia | Original Article

Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool

Authors: Verena Glöckner, Mathias W. Pletz, Gernot Rohde, Jan Rupp, Martin Witzenrath, Grit Barten-Neiner, Martin Kolditz, for the CAPNETZ Study Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2022

Login to get access

Abstract

There are few data on mortality after discharge with community-acquired pneumonia (CAP). Therefore, we evaluated risk factors for 30-day post-discharge mortality after CAP. We included all patients of the prospective multi-national CAPNETZ study between 2002 and 2018 with (1) hospitalized CAP, (2) survival until discharge, and (3) complete follow-up data. The study endpoint was death within 30 days after discharge. We evaluated risk factors including demographics, comorbidities, admission CAP severity, and laboratory values and treatment-related factors in uni- and multivariable analyses. A total of 126 (1.6%) of 7882 included patients died until day 30 after discharge, corresponding to 26% of all 476 deaths. After multivariable analysis, we identified 10 independent risk factors: higher age, lower BMI, presence of diabetes mellitus, chronic renal or chronic neurological disease (other than cerebrovascular diseases), low body temperature or higher thrombocytes on admission, extended length of hospitalization, oxygen therapy during hospitalization, and post-obstructive pneumonia. By addition these factors, we calculated a risk score with an AUC of 0.831 (95%CI 0.822–0.839, p < 0.001) for prediction of post-discharge mortality. Early post-discharge deaths account for ¼ of all CAP-associated deaths and are associated with patient- and CAP-severity-related risk factors. Additional studies are necessary to replicate our findings in independent cohorts. Study registration: NCT 02139163.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kolditz M, Braeken D, Ewig S, Rohde G (2016) Severity assessment and the immediate and long-term prognosis in community-acquired pneumonia. Semin Respir Crit Care Med 37(6):886–896CrossRef Kolditz M, Braeken D, Ewig S, Rohde G (2016) Severity assessment and the immediate and long-term prognosis in community-acquired pneumonia. Semin Respir Crit Care Med 37(6):886–896CrossRef
2.
go back to reference Holter JC, Ueland T, Jenum PA, Muller F, Brunborg C, Froland SS, Aukrust P, Husebye E, Heggelund L (2016) Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study. PLoS One 11(2):e0148741CrossRef Holter JC, Ueland T, Jenum PA, Muller F, Brunborg C, Froland SS, Aukrust P, Husebye E, Heggelund L (2016) Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study. PLoS One 11(2):e0148741CrossRef
3.
go back to reference Bruns AH, Oosterheert JJ, Cucciolillo MC, El MR, Groenwold RH, Prins JM, Hoepelman AI (2011) Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 17(5):763–768CrossRef Bruns AH, Oosterheert JJ, Cucciolillo MC, El MR, Groenwold RH, Prins JM, Hoepelman AI (2011) Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 17(5):763–768CrossRef
4.
go back to reference Kolditz M, Tesch F, Mocke L, Hoffken G, Ewig S, Schmitt J (2016) Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study. Respir Med 121:32–38CrossRef Kolditz M, Tesch F, Mocke L, Hoffken G, Ewig S, Schmitt J (2016) Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study. Respir Med 121:32–38CrossRef
5.
go back to reference Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW (2018) Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA 320(24):2542–2552CrossRef Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW (2018) Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA 320(24):2542–2552CrossRef
6.
go back to reference Capelastegui A, Espana PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A (2009) Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia. Thorax 64(6):496–501CrossRef Capelastegui A, Espana PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A (2009) Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia. Thorax 64(6):496–501CrossRef
7.
go back to reference Metersky ML, Waterer G, Nsa W, Bratzler DW (2012) Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 142(2):476–481CrossRef Metersky ML, Waterer G, Nsa W, Bratzler DW (2012) Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 142(2):476–481CrossRef
8.
go back to reference Lindenauer PK, Normand SL, Drye EE, Lin Z, Goodrich K, Desai MM, Bratzler DW, O’Donnell WJ, Metersky ML, Krumholz HM (2011) Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 6(3):142–150CrossRef Lindenauer PK, Normand SL, Drye EE, Lin Z, Goodrich K, Desai MM, Bratzler DW, O’Donnell WJ, Metersky ML, Krumholz HM (2011) Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 6(3):142–150CrossRef
9.
go back to reference Aliberti S, Zanaboni AM, Wiemken T, Nahas A, Uppatla S, Morlacchi LC, Peyrani P, Blasi F, Ramirez J (2013) Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J 42(3):742–749CrossRef Aliberti S, Zanaboni AM, Wiemken T, Nahas A, Uppatla S, Morlacchi LC, Peyrani P, Blasi F, Ramirez J (2013) Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J 42(3):742–749CrossRef
10.
go back to reference Freburger JK, Chou A, Euloth T, Matcho B (2020) Variation in acute care rehabilitation and 30-day hospital readmission or mortality in adult patients with pneumonia. JAMA Netw Open 3(9):e2012979CrossRef Freburger JK, Chou A, Euloth T, Matcho B (2020) Variation in acute care rehabilitation and 30-day hospital readmission or mortality in adult patients with pneumonia. JAMA Netw Open 3(9):e2012979CrossRef
11.
go back to reference Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W, Dromann D, Flick H, Gatermann S, Kruger S, Nehls W, Panning M, Rademacher J, Rohde G, Rupp J, Schaaf B, Heppner HJ, Krause R, Ott S, Welte T, Witzenrath M (2021) Management of adult community-acquired pneumonia and prevention - update 2021 - guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (OGP), the Austrian Society for Infectious and Tropical Diseases (OGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI). Pneumologie 75(9):665–729CrossRef Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W, Dromann D, Flick H, Gatermann S, Kruger S, Nehls W, Panning M, Rademacher J, Rohde G, Rupp J, Schaaf B, Heppner HJ, Krause R, Ott S, Welte T, Witzenrath M (2021) Management of adult community-acquired pneumonia and prevention - update 2021 - guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (OGP), the Austrian Society for Infectious and Tropical Diseases (OGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI). Pneumologie 75(9):665–729CrossRef
12.
go back to reference Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG (2019) Diagnosis and treatment of adults with community-acquired pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45–e67CrossRef Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG (2019) Diagnosis and treatment of adults with community-acquired pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45–e67CrossRef
13.
go back to reference Welte T, Suttorp N, Marre R (2004) CAPNETZ-community-acquired pneumonia competence network. Infection 32(4):234–238CrossRef Welte T, Suttorp N, Marre R (2004) CAPNETZ-community-acquired pneumonia competence network. Infection 32(4):234–238CrossRef
14.
go back to reference Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382CrossRef Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382CrossRef
15.
go back to reference Çınarka H, Yurt S, Tanrıverdi E, Uğur Chousein E, Turan D, Yıldırım Z, Çörtük M, Çetinkaya E (2020) Post discharge short term mortality in hospitalized patients with community-acquired pneumonia. Haydarpasa Numune Med J 60(4):6 Çınarka H, Yurt S, Tanrıverdi E, Uğur Chousein E, Turan D, Yıldırım Z, Çörtük M, Çetinkaya E (2020) Post discharge short term mortality in hospitalized patients with community-acquired pneumonia. Haydarpasa Numune Med J 60(4):6
16.
go back to reference Kesselmeier M, Pletz MW, Blankenstein AL, Scherag A, Bauer T, Ewig S, Kolditz M (2021) Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia. Clin Microbiol Infect 27(9):1345 e1-1345 e6CrossRef Kesselmeier M, Pletz MW, Blankenstein AL, Scherag A, Bauer T, Ewig S, Kolditz M (2021) Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia. Clin Microbiol Infect 27(9):1345 e1-1345 e6CrossRef
18.
go back to reference Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ (2008) Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 46(4):550–556CrossRef Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ (2008) Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 46(4):550–556CrossRef
19.
go back to reference Toledo D, Soldevila N, Torner N, Perez-Lozano MJ, Espejo E, Navarro G, Egurrola M, Dominguez A, F.I.S.P.I.W.G. On-behalf of the Project (2018) Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions. BMJ Open 8(3):e020243CrossRef Toledo D, Soldevila N, Torner N, Perez-Lozano MJ, Espejo E, Navarro G, Egurrola M, Dominguez A, F.I.S.P.I.W.G. On-behalf of the Project (2018) Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions. BMJ Open 8(3):e020243CrossRef
20.
go back to reference Petersen PT, Egelund GB, Jensen AV, Andersen SB, Pedersen MF, Rohde G, Ravn P (2018) Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 37(6):1103–1111CrossRef Petersen PT, Egelund GB, Jensen AV, Andersen SB, Pedersen MF, Rohde G, Ravn P (2018) Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 37(6):1103–1111CrossRef
21.
go back to reference Rolston KVI, Nesher L (2018) Post-obstructive pneumonia in patients with cancer: a review. Infect Dis Ther 7(1):29–38CrossRef Rolston KVI, Nesher L (2018) Post-obstructive pneumonia in patients with cancer: a review. Infect Dis Ther 7(1):29–38CrossRef
22.
go back to reference Abers MS, Sandvall BP, Sampath R, Zuno C, Uy N, Yu VL, Stager CE, Musher DM (2016) Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis 62(8):957–961CrossRef Abers MS, Sandvall BP, Sampath R, Zuno C, Uy N, Yu VL, Stager CE, Musher DM (2016) Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis 62(8):957–961CrossRef
23.
go back to reference Musher DM, Abers MS, Corrales-Medina VF (2019) Acute infection and myocardial infarction. N Engl J Med 380(2):171–176CrossRef Musher DM, Abers MS, Corrales-Medina VF (2019) Acute infection and myocardial infarction. N Engl J Med 380(2):171–176CrossRef
24.
go back to reference Prina E, Ferrer M, Ranzani OT, Polverino E, Cilloniz C, Moreno E, Mensa J, Montull B, Menendez R, Cosentini R, Torres A (2013) Thrombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest 143(3):767–775CrossRef Prina E, Ferrer M, Ranzani OT, Polverino E, Cilloniz C, Moreno E, Mensa J, Montull B, Menendez R, Cosentini R, Torres A (2013) Thrombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest 143(3):767–775CrossRef
25.
go back to reference Cangemi R, Casciaro M, Rossi E, Calvieri C, Bucci T, Calabrese CM, Taliani G, Falcone M, Palange P, Bertazzoni G, Farcomeni A, Grieco S, Pignatelli P, Violi F, S.S. Group, S.S. Group (2014) Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 64(18):1917–1925CrossRef Cangemi R, Casciaro M, Rossi E, Calvieri C, Bucci T, Calabrese CM, Taliani G, Falcone M, Palange P, Bertazzoni G, Farcomeni A, Grieco S, Pignatelli P, Violi F, S.S. Group, S.S. Group (2014) Platelet activation is associated with myocardial infarction in patients with pneumonia. J Am Coll Cardiol 64(18):1917–1925CrossRef
26.
go back to reference Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Ten Berg JM, Noordzij PG, Van de Garde EMW, Bos WJW, G. Ovidius Study (2017) High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology 22(5):1000–1006CrossRef Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Ten Berg JM, Noordzij PG, Van de Garde EMW, Bos WJW, G. Ovidius Study (2017) High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology 22(5):1000–1006CrossRef
Metadata
Title
Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool
Authors
Verena Glöckner
Mathias W. Pletz
Gernot Rohde
Jan Rupp
Martin Witzenrath
Grit Barten-Neiner
Martin Kolditz
for the CAPNETZ Study Group
Publication date
01-04-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2022
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-022-04416-5

Other articles of this Issue 4/2022

European Journal of Clinical Microbiology & Infectious Diseases 4/2022 Go to the issue